Immune status and prognosis of stage II and III primary malignant melanoma: An analysis including 77 cases of acral lentiginous melanoma

J Dermatol. 2023 Apr;50(4):e121-e122. doi: 10.1111/1346-8138.16650. Epub 2022 Nov 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Melanoma* / diagnosis
  • Melanoma* / pathology
  • Melanoma, Cutaneous Malignant
  • Prognosis
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / pathology